The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States
Dados Bibliográficos
| ID | 11032131 |
|---|---|
| Autores | Jessica Tuttle (Centers for Disease Control and Prevention), R T Chen, Heikki Rantala (0000-0002-4716-6564), James D Cherry (0000-0003-1600-0710), P H Rhodes, Phillip Rhodes, Stephen C Hadler (0000-0002-2985-7337), S Hadler |
| Ano | 1997 |
| Volume | 87 |
| Fascículo | 12 |
| Páginas | 2045-2048 |
| Data de publicação | 1997-12-01 |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | American Journal of Public Health (JOURNAL) |
| Identificadores do periódico | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Editora | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.87.12.2045 |
| PMID | 9431302 |
| OpenAlex | W2030563356 |
| Idioma | EN |
| Citações recebidas | 1 |
| Referências citadas | 7 |
OBJECTIVES: This study examined whether there is a risk that tetanus-toxoid-containing vaccines could cause Guillain-Barré syndrome and, if so, how large the risk is. METHODS: This study was based on previous active surveillance epidemiological studies of Guillain-Barré syndrome and vaccination history. RESULTS: A background rate of 0.3 cases of Guillain-Barré syndrome per million person-weeks has been estimated. By chance, 2.2 people with the syndrome would have received tetanus-toxoid-containing vaccine within the 6 weeks before onset, yet only 1 person had done so. Data on children show similar results. CONCLUSIONS: If an association exists, it must be extremely rare and not of public health significance
Guillain-Barre syndrome · Pathology · Public health · Tetanus · Toxoid · Vaccination · Bacterial Infections and Vaccines · Epidemiology · Immunology · Internal Medicine · Intramuscular injections and effects · Medicine · Peripheral Neuropathies and Disorders · Pediatrics
| Citações por ano | 0,03 |
|---|---|
| Intervalo de citações | 1997 - 1997 (1) |
| Altamente citado | Não |